Hemiplegia and upper limb hand dysfunction following ischemic/hemorrhagic stroke
Conditions
Interventions
Routine Rehabilitation Control Group:Conventional Upper Limb Rehabilitation Intervention
SMART Intervention Experimental Group:SMART structured upper limb rehabilitation intervention
Sponsors
Lanzhou City Traditional Chinese Medicine Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Meets the diagnostic criteria outlined in the "China Guidelines for Diagnosis and Treatment of Acute Ischemic Stroke 2023" and the "China Guidelines for Diagnosis and Treatment of Intracerebral Hemorrhage 2023", with a definitive diagnosis confirmed by cranial CT/MRI imaging studies. 2.The disease course lasts 3 to 12 months, during which the patient is in the recovery phase of stroke. 3.Age range: 18–75 years; gender unrestricted; 4.The Fugl-Meyer Motor Function Score (FMA-UE) for the affected upper limb ranges from 22 to 58 points, indicating significant hand dysfunction. 5.The Mini-Mental State Examination (MMSE) score is =17; the patient exhibits clear consciousness and no significant cognitive impairment, and can cooperate fully with rehabilitation training and assessment. 6.Life signs are stable, with no severe complications. 7.The patient and their family members have provided full informed consent, voluntarily participated in this study, and signed the written informed consent form.
Exclusion criteria
Exclusion criteria: 1.Severe cognitive impairment, sensory aphasia, mixed aphasia; inability to understand instructions or cooperate with training and assessment procedures. 2.The patient has severe combined dysfunction of vital organs such as the heart, liver, kidneys, and respiratory system, making rehabilitation interventions intolerable. 3.The modified Ashworth Spasm Scale (MAS) for the affected upper limb shows a spasm grade>3, with severe spasms significantly impairing athletic performance. 4.Orthopedic or neurological conditions such as fractures, dislocations, rheumatoid arthritis, or peripheral nerve injuries in the affected upper limb that interfere with hand function assessment and training. 5.Patients with a history of traumatic brain injury, Parkinson's disease, motor neuron diseases, or other central nervous system disorders; 6.Individuals who have undergone interventions affecting upper limb function, such as botulinum toxin injections or surgical procedures, within the past 3 months; 7.Women during pregnancy or lactation, individuals with mental disorders, and those with alcoholism or drug dependence;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fugl-Meyer Upper Extremity Function Assessment (FMA-UE);Wolf Motor Function (WMFT);Modified Barthel Index (MBI);Lindmark Functional Assessment Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Motor Evoked Potential (MEP);Quantitative Sensory Testing of the Upper Limb; | — |
Countries
China
Contacts
Public Contacttao Xu
Lanzhou City Traditional Chinese Medicine Hospital
Outcome results
None listed